Browsing by Author "Reis, Eliana Almeida Gomes"
Now showing items 30-49 of 49
-
Lewis(x)-containing oligosaccharide attenuates schistosome egg antigen-induced immune depression in human schistosomiasis
Velupillai, Palanivel et al. | Date Issued: 2000 -
Naïve donor responses to Schistosoma mansoni soluble egg antigens.
Reis, Eliana Almeida Gomes et al. | Date Issued: 2007 -
NK and NKT cell dynamics after rituximab therapy for systemic lupus erythematosus and rheumatoid arthritis
Reis, Eliana Almeida Gomes et al. | Date Issued: 2009 -
Oxidative stress markers correlate with renal dysfunction and thrombocytopenia in severe leptospirosis.
Araújo, Alan Moreira de et al. | Date Issued: 2014 -
Óxido Nítrico no soro de pacientes com Leptospirose grave
Maciel, Elves Anderson Pires et al. | Date Issued: 2004 -
Pesquisa de anticorpos antinucleossoma em lúpus eitematoso sistêmico
Lima, Isabella et al. | Date Issued: 2007Objetivos: determinar a freqüência dos anticorpos antinucleossoma (AN) em lúpus eritematoso sistêmico (LES) e avaliar a associação desses anticorpos com a atividade de doença. Métodos: estudo de corte transversal em que ... -
Plasma lipoproteins in visceral leishmaniasis and their effect on Leishmania-infected macrophages
Soares, Neci Matos et al. | Date Issued: 2010 -
Potential immunomodulatory effects of plant lectins in Schistosoma mansoni infection
Reis, Eliana Almeida Gomes et al. | Date Issued: 2008 -
Repeated praziquantel treatments remodel the genetic and spatial landscape of schistosomiasis risk and transmission
Barbosa, Lúcio Macedo et al. | Date Issued: 2016 -
Schistosoma mansoni population structure and persistence after praziquantel treatment in two villages of Bahia, Brazil
Blanton, Ronald Edward et al. | Date Issued: 2011 -
Schistosoma mansoni triose phosphate isomerase peptide MAP4 is able to trigger naïve donor immune response towards a type-1 cytokine profile.
Reis, Eliana Almeida Gomes et al. | Date Issued: 2008 -
Schizodeme analysis of Trypanosoma cruzi Colombian strain clones isolated from the acute phase of murine infection
Camandaroba, Edson Luiz Paes et al. | Date Issued: 2006 -
Sensitivity of polymerase chain reaction for detection of known aliquots of Trypanosoma cruzi in the blood of mice: an in vitro study.
Campos, Rozalia Mendes Figueira et al. | Date Issued: 2002A sensibilidade da reação em cadeia da polimerase (PCR) para revelar a presença de números conhecidos de tripomastigotas no sangue de camundongos, foi investigada em três experimentos separados. No primeiro, foram ... -
Sera from Visceral Leishmaniasis Patients Display Oxidative Activity and Affect the TNF-αProduction by MacrophagesIn Vitro
Soares, Neci Matos et al. | Date Issued: 2017 -
Severe Jaccoud's arthropathy in systemic lupus erythematosus
Santiago, Mittermayer Barreto et al. | Date Issued: 2015 -
Soluble intercellular adhesion molecules in human schistosomiasis: correlations with disease severity and decreased responsiveness to egg antigens
Secor, William E et al. | Date Issued: 1994 -
The dynamics of dengue virus serotype 3 introduction and dispersion in the state of Bahia, Brazil
Melo, Paulo Roberto Santana de et al. | Date Issued: 2007 -
The relative contribution of immigration or local increase for persistence of urban schistosomiasis in Salvador, Bahia, Brazil
Blanton, Ronald Edward et al. | Date Issued: 2015 -
Trypanosoma cruzi: susceptibility to chemotherapy with benznidazole of clones isolated from the highly resistant Colombian strain.
Camandaroba, Edson Luiz Paes et al. | Date Issued: 2003A presente investigação visa avaliar a suscetibilidade ao benzonidazol de sete clones isolados da cepa Colombiana do Trypanosoma cruzi, protótipo do biodema III , altamente resistente aos quimioterápicos. Os clones préviamente ... -
Uso do Rituximabe para o tratamento da plaquetopenia do lúpus eritematoso sistêmico: eficácia clínica e efeito nas moléculas de co-estimulação
Santiago, Mittermayer Barreto et al. | Date Issued: 2006Plaquetopenia é uma complicação não raramente vista no contexto do lúpus eritematoso sistêmico (LES). O seu tratamento inclui o uso de corticosteróide, imunossupressores, imunoglobulina humana e, eventualmente, ...